Filing Details

Accession Number:
0000950170-24-083964
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-16 16:47:28
Reporting Period:
2024-07-15
Accepted Time:
2024-07-16 16:47:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1861560 Nuvalent Inc. NUVL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1907812 Emily Conley C/O Nuvalent, Inc.
One Broadway, 14Th Floor
Cambridge MA 02142
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2024-07-15 5,000 $13.79 7,507 No 4 M Direct
Class A Common Stock Disposition 2024-07-15 700 $79.43 6,807 No 4 S Direct
Class A Common Stock Disposition 2024-07-15 1,900 $80.29 4,907 No 4 S Direct
Class A Common Stock Disposition 2024-07-15 2,195 $81.40 2,712 No 4 S Direct
Class A Common Stock Disposition 2024-07-15 205 $81.93 2,507 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (Right to Buy) Disposition 2024-07-15 5,000 $0.00 5,000 $13.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,667 2032-02-02 No 4 M Direct
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2023.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.80 to $79.78, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) of this Form 4.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.89 to $80.84, inclusive.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.90 to $81.88, inclusive.
  5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.92 to $81.93, inclusive.
  6. The shares underlying this option have vested or shall vest over the three years following February 2, 2022 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.